Willis Towers Watson said revenue for Q3 2025 was $2.29 billion, flat compared to the prior-year quarter due to the sale of TRANZACT, and organic revenue increased 5%. Adjusted diluted earnings per share was $3.07, up 11% from $2.77 in the prior-year quarter.

1. 01

   Willis Towers Watson said revenue for Q3 2025 was $2.29 billion, flat compared to the prior-year quarter due to the sale of TRANZACT, and organic revenue increased 5%. Adjusted diluted earnings per share was $3.07, up 11% from $2.77 in the prior-year quarter.

2. 02

   The company said adjusted operating income for Q3 2025 was $467 million, up 13% from $414 million in the prior-year quarter, and adjusted operating margin was 20.4%, an increase of 230 basis points.

3. 03

   Willis Towers Watson said Risk & Broking revenue for Q3 2025 was $1.01 billion, up 7% from $940 million in the prior-year quarter (organic growth of 6%), and operating margin was 18.8%, an increase of 70 basis points.

4. 04

   The company said cash flows from operating activities for the 9 months ended September 30, 2025 were $1.0 billion, and free cash flow was $838 million. During Q3, it repurchased 1,848,098 ordinary shares for $600 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.